Report cover image

North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, C

Publisher Market Research Future
Published May 18, 2024
Length 107 Pages
SKU # RESFT18928090

Description

North America & Europe Epilepsy Market Research Report Information Forecast to 2032 By Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe)



It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures are a common symptom of epilepsy, a persistent neurological illness that damages the brain. Uncontrolled electrical activity in the brain, or seizures, can alter behavior, consciousness, movement, and sensation.

Growth in the epilepsy market in North America and Europe is mostly due to rising knowledge and understanding of the condition, as well as rising occurrences of epilepsy in these regions. Nonetheless, it is anticipated that the adverse effects of antiepileptic medications will limit the epilepsy market's expansion in North America and Europe. However, growing clinical trials for items used in epilepsy diagnosis and treatment research, as well as increased investment in these areas, are expected to open profitable potential for the market.

Market Segmentation

Generalized epilepsy and focal epilepsy are the two categories into which the epilepsy markets in North America and Europe have been divided.

The epilepsy market in North America and Europe is divided into two segments: diagnosis and therapy.

The market has been divided into hospitals and clinics, diagnostic centers, and other end users.

Growth at a compound annual growth rate (CAGR) of 7.88% is anticipated in the North American epilepsy market, which was valued at USD 6,888.72 million in 2022. The US and Canada are two more divisions of North America.

Important Players

Leading companies in the market include Sun Pharmaceutical Industries Ltd., UCB S. A., H. Lundbeck A/S., Johnson & Johnson Services, Inc., Novartis AG, GlaxoSmithKline, Boston Scientific Corporation, Abbott, Cipla Ltd., and Eisai Co., Ltd.

Table of Contents

107 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Incidences Of Epilepsy In North America And Europe Region
4.2.2 Rising Awareness And Understanding Of Epilepsy
4.3 Restraints
4.3.1 Side Effects Associated With Antiepileptic Drugs
4.4 Opportunity
4.4.1 Increasing Investment For Epilepsy Diagnosis & Treatment Research
4.4.2 Growing Clinical Trials For Epilepsy Treatment Products
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Threat Of New Entrants
5.1.2 Bargaining Power Of Suppliers
5.1.3 Threat Of Substitutes
5.1.4 Bargaining Power Of Buyers
5.1.5 Intensity Of Rivalry
5.2 Impact Of Covid-19 On The North America And Europe Epilepsy Market
5.3 R&D Investment By Major Pharmaceutical And Medical Device Companies On Epilepsy
5.4 List Of Failed Clinical Trials For Epilepsy Drug
5.5 Clinical Trial Landscape For Epilepsy Drugs And Devices
5.6 Current Trends On Seeg Procedures
5.7 Qualitative Overview On Epilepsy Treatment Management Other Than Drugs And Surgery
6 North America And Europe Epilepsy Market, By Condition
6.1 Overview
6.2 Generalized Epilepsy
6.3 Focal Epilepsy
7 North America And Europe Epilepsy Market, By Diagnosis & Treatment
7.1 Overview
7.2 Diagnosis
7.2.1 Blood Tests
7.2.2 Electroencephalogram (Eeg) Imaging Test
7.2.3 Imaging Scan
7.2.3.1 Magnetic Resonance Imaging (Mri) Scan
7.2.3.2 Computerized Tomography (Ct) Scan
7.2.3.3 Others
7.3 Treatment
7.3.1 Drug Class
7.3.1.1 First Generation Anti-epileptic Drugs
7.3.1.2 Second Generation Anti-epileptic Drugs
7.3.1.3 Third Generation Anti-epileptic Drugs
7.3.2 Surgery
7.3.2.1 Focal Resection
7.3.2.2 Lesionectomy
7.3.2.3 Corpus Callosotomy
7.3.2.4 Others
7.3.3 Therapies
7.3.3.1 Vagus Nerve Stimulation
7.3.3.2 Deep Brain Stimulation
7.3.3.3 Responsive Neurostimulation
7.3.3.4 Thermocoagulation
8 North America And Europe Epilepsy Market, By End User
8.1 Overview
8.2 Hospitals And Clinics
8.3 Diagnostic Centers
8.4 Others
9 North America & Europe Epilepsy Market, By Region
9.1 North America
9.1.1 Us
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Uk
9.2.4 Italy
9.2.5 Spain
9.2.6 Rest Of Europe
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, 2022
10.3 Competitor Dashboard
10.4 Public Players Stock Summary
10.5 Comparative Analysis: Key Players Finanical
10.6 Key Developments & Growth Strategies
10.6.1 Product Launch / Product Approval
10.6.2 Acquisition
11 Company Profiles
11.1 Johnson & Johnson Services, Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategy
11.2 Boston Scientific Corporation
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offered
11.2.4 Key Developments
11.2.5 Swot Analysis
11.2.6 Key Strategies
11.3 Abbott
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategies
11.4 Cipla Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offered
11.4.4 Key Developments
11.4.5 Swot Analysis
11.4.6 Key Strategies
11.5 Ucb S.A
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offered
11.5.4 Key Developments
11.5.5 Key Strategies
11.6 H. Lundbeck A/S
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offered
11.6.4 Key Developments
11.6.5 Key Strategies
11.7 Eisai Co., Ltd
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offered
11.7.4 Key Developments
11.7.5 Key Strategies
11.8 Novartis Ag
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offered
11.8.4 Key Developments
11.8.5 Swot Analysis
11.8.6 Key Strategies
11.9 Glaxosmithkline Plc
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offered
11.9.4 Key Developments
11.9.5 Key Strategies
11.10 Sun Pharmaceutical Industries Limited
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offered
11.10.4 Key Developments
11.10.5 Key Strategies
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 R&D Investment By Major Pharmaceutical And Medical Device Companies On Epilepsy
Table 3 List Of Failed Clinical Trials For Epilepsy Drug
Table 4 North America And Europe Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 5 North America And Europe Epilepsy Market, For Generalized Epilepsy, By Region, 2019–2032 (Usd Million)
Table 6 North America And Europe Epilepsy Market, For Focal Epilepsy, By Region, 2019–2032 (Usd Million)
Table 7 North America And Europe Epilepsy Market, Diagnosis & Treatment Segment Attractiveness, 2022-2032 (Usd Million)
Table 8 North America And Europe Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 9 North America And Europe Epilepsy Market, For Diagnosis, By Region, 2019–2032 (Usd Million)
Table 10 North America And Europe Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 11 North America And Europe Epilepsy Market, For Blood Tests, By Region, 2019–2032 (Usd Million)
Table 12 North America And Europe Epilepsy Market, For Electroencephalogram (Eeg) Imaging Test, By Region, 2019–2032 (Usd Million)
Table 13 North America And Europe Epilepsy Market, For Imaging Scan, By Region, 2019–2032 (Usd Million)
Table 14 North America And Europe Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Usd Million)
Table 15 North America And Europe Epilepsy Market, For Magnetic Resonance Imaging (Mri) Scan, By Region, 2019–2032 (Usd Million)
Table 16 North America And Europe Epilepsy Market, For Computerized Tomography (Ct) Scan, By Region, 2019–2032 (Usd Million)
Table 17 North America And Europe Epilepsy Market, For Others, By Region, 2019–2032 (Usd Million)
Table 18 North America And Europe Epilepsy Market, For Treatment, By Region, 2019–2032 (Usd Million)
Table 19 North America And Europe Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 20 North America And Europe Epilepsy Market, For Drug Class, By Region, 2019–2032 (Usd Million)
Table 21 North America And Europe Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 22 North America And Europe Epilepsy Market, For First Generation Anti-epileptic Drugs, By Region, 2019–2032 (Usd Million)
Table 23 North America And Europe Epilepsy Market, For Second Generation Anti-epileptic Drugs, By Region, 2019–2032 (Usd Million)
Table 24 North America And Europe Epilepsy Market, For Third Generation Anti-epileptic Drugs, By Region, 2019–2032 (Usd Million)
Table 25 North America And Europe Epilepsy Market, For Surgery, By Region, 2019–2032 (Usd Million)
Table 26 North America And Europe Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 27 North America And Europe Epilepsy Market, For Focal Resection, By Region, 2019–2032 (Usd Million)
Table 28 North America And Europe Epilepsy Market, For Lesionectomy, By Region, 2019–2032 (Usd Million)
Table 29 North America And Europe Epilepsy Market, For Corpus Callosotomy, By Region, 2019–2032 (Usd Million)
Table 30 North America And Europe Epilepsy Market, For Others, By Region, 2019–2032 (Usd Million)
Table 31 North America And Europe Epilepsy Market, For Therapies, By Region, 2019–2032 (Usd Million)
Table 32 North America And Europe Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 33 North America And Europe Epilepsy Market, For Vagus Nerve Stimulation, By Region, 2019–2032 (Usd Million)
Table 34 North America And Europe Epilepsy Market, For Deep Brain Stimulation, By Region, 2019–2032 (Usd Million)
Table 35 North America And Europe Epilepsy Market, For Responsive Neurostimulation, By Region, 2019–2032 (Usd Million)
Table 36 North America And Europe Epilepsy Market, For Thermocoagulation, By Region, 2019–2032 (Usd Million)
Table 37 North America And Europe Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 38 North America And Europe Epilepsy Market, For Hospitals And Clinics, By Region, 2019–2032 (Usd Million)
Table 39 North America And Europe Epilepsy Market, For Diagnostic Centers, By Region, 2019–2032 (Usd Million)
Table 40 North America And Europe Epilepsy Market, For Others, By Region, 2019–2032 (Usd Million)
Table 41 North America: Epilepsy Market, By Country, 2019–2032 (Usd Million)
Table 42 North America: Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 43 North America: Epilepsy Market, By Diagnosis & Treatment, 2019-2032 (Usd Million)
Table 44 North America: Epilepsy Market, For Diagnosis, By Type, 2019-2032 (Usd Million)
Table 45 North America: Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Usd Million)
Table 46 North America: Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 47 North America: Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 48 North America: Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 49 North America: Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 50 North America: Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 51 Us: Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 52 Us: Epilepsy Market, By Diagnosis & Treatment, 2019-2032 (Usd Million)
Table 53 Us: Epilepsy Market, For Diagnosis, By Type, 2019-2032 (Usd Million)
Table 54 Us: Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Usd Million)
Table 55 Us: Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 56 Us: Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 57 Us: Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 58 Us: Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 59 Us: Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 60 Canada: Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 61 Canada: Epilepsy Market, By Diagnosis & Treatment, 2019-2032 (Usd Million)
Table 62 Canada: Epilepsy Market, For Diagnosis, By Type, 2019-2032 (Usd Million)
Table 63 Canada: Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Usd Million)
Table 64 Canada: Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 65 Canada: Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 66 Canada: Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 67 Canada: Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 68 Canada: Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 69 Europe Epilepsy Market, By Country, 2019–2032 (Usd Million)
Table 70 Europe Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 71 Europe Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 72 Europe Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 73 Europe Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table 74 Europe Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 75 Europe Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 76 Europe Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 77 Europe Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 78 Europe Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 79 Germany Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 80 Germany Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 81 Germany Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 82 Germany Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table 83 Germany Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 84 Germany Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 85 Germany Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 86 Germany Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 87 Germany Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 88 France Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 89 France Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table France Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table France Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table France Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table France Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 94 France Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 95 France Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 96 France Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 97 Uk Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 98 Uk Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 99 Uk Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 100 Uk Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table 101 Uk Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table Uk Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table Uk Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 104 Uk Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 105 Uk Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table Italy Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 107 Italy Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 108 Italy Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 109 Italy Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table 110 Italy Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 111 Italy Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 112 Italy Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 113 Italy Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 114 Italy Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 115 Spain Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 116 Spain Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 117 Spain Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 118 Spain Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table 119 Spain Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 120 Spain Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 121 Spain Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 122 Spain Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 123 Spain Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 124 Rest Of Europe Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 125 Rest Of Europe Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 126 Rest Of Europe Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 127 Rest Of Europe Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Volume)
Table 128 Rest Of Europe Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 129 Rest Of Europe Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 130 Rest Of Europe Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 131 Rest Of Europe Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 132 Rest Of Europe Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 133 Public Players Stock Summary
Table 134 Comparative Analysis: Key Players Finanical
Table 135 Product Launch/ Product Approval
Table 136 Acquisition
Table 137 Johnson & Johnson Services, Inc.: Products Offered
Table 138 Boston Scientific Corporation: Products Offered
Table 139 Boston Scientific Corporation: Key Developments
Table 140 Abbott: Products Offered
Table 141 Cipla Ltd: Products Offered
Table 142 Ucb S.A: Product Offered
Table 143 Ucb S.A: Key Developments
Table 144 H. Lundbeck A/S: Product Offered
Table 145 Eisai Co., Ltd: Product Offered
Table 146 Novartis Ag: Products Offered
Table 147 Glaxosmithkline Plc: Prodcuts Offered
Table 148 Sun Pharmaceutical Industries Limited: Products Offered
List Of Figures
Figure 1 North America And Europe Epilepsy Market: Structure
Figure 2 North America And Europe Epilepsy Market: Market Growth Factor Analysis (2022-2032)
Figure 3 Driver Impact Analysis (2023-2032)
Figure 4 Restraint Impact Analysis (2022-2032)
Figure 5 Porter's Five Forces Analysis: North America And Europe Epilepsy Market
Figure 6 North America And Europe Epilepsy Market, Condition Segment Attractiveness, 2022-2032 (Usd Million)
Figure 7 North America And Europe Epilepsy Market, By Condition, 2022 & 2032 (Usd Million)
Figure 8 North America And Europe Epilepsy Market Share (%), By Condition, 2022
Figure 9 North America And Europe Epilepsy Market, By Diagnosis & Treatment, 2022 & 2032 (Usd Million)
Figure 10 North America And Europe Epilepsy Market Share (%), By Diagnosis & Treatment, 2022
Figure 11 North America And Europe Epilepsy Market, End User Segment Attractiveness, 2022-2032 (Usd Million)
Figure 12 North America And Europe Epilepsy Market, By End User, 2022 & 2032 (Usd Million)
Figure 13 North America And Europe Epilepsy Market Share (%), By End User, 2022
Figure 14 North America Market Analysis: Epilepsy Market, 2019-2032 (Usd Million)
Figure 15 North America: Epilepsy Market, By Country, 2022 & 2032 (Usd Million)
Figure 16 North America: Epilepsy Market Share (%), By Country, 2022
Figure 17 Europe Market Analysis: Epilepsy Market, 2019-2032 (Usd Million)
Figure 18 Europe Epilepsy Market Share, By Country, 2022 (% Share)
Figure 19 Europe Epilepsy Market, By Country, 2022 & 2032 (Usd Million)
Figure 20 Epilepsy Market Players: Competitive Analsis, 2022
Figure 21 Competitor Dashboard: North America & Europe Epilepsy Market
Figure 22 Johnson & Johnson Services, Inc.: Financial Overview Snapshot
Figure 23 Johnson & Johnson Services, Inc.: Swot Analysis
Figure 24 Boston Scientific Corporation: Financial Overview Snapshot
Figure 25 Boston Scientific Corporation: Swot Analysis
Figure 26 Abbott: Financial Overview Snapshot
Figure 27 Abbott: Swot Analysis
Figure 28 Cipla Ltd: Financial Overview
Figure 29 Cipla Ltd: Swot Analysis
Figure 30 Ucb S.A: Financial Overview Snapshot
Figure 31 H. Lundbeck A/S: Financial Overview Snapshot
Figure 32 Eisai Co., Ltd: Financial Overview Snapshot
Figure 33 Novartis Ag: Financial Overview
Figure 34 Novartis Ag: Swot Analysis
Figure 35 Glaxosmithkline Plc: Financial Overview
Figure 36 Sun Pharmaceutical Industries Ltd.: Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us